Zhang F - Search Results

1

Activation of NOD1 on tumor-associated macrophages augments CD8⁺ T cell-mediated antitumor immunity in hepatocellular carcinoma.

Zhang F, Jiang Q, Cai J, Meng F, Tang W, Liu Z, Lin X, Liu W, Zhou Y, Shen X, Xue R, Dong L, Zhang S. Zhang F, et al. Among authors: zhang s. Sci Adv. 2024 Oct 4;10(40):eadp8266. doi: 10.1126/sciadv.adp8266. Epub 2024 Oct 2. Sci Adv. 2024. PMID: 39356756 Free PMC article.

2

The prognostic significance of microRNA-221 in hepatocellular carcinoma: An updated meta-analysis.

Liu W, Hu K, Zhang F, Lu S, Chen R, Ren Z, Yin X. Liu W, et al. Among authors: zhang f. Int J Biol Markers. 2021 Jun;36(2):17246008211032689. doi: 10.1177/17246008211032689. Int J Biol Markers. 2021. PMID: 34374576 Free article.

3

The Prognostic Value of the Albumin to Gamma-Glutamyltransferase Ratio in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation.

Liu W, Zhang F, Quan B, Li M, Lu S, Li J, Chen R, Yin X. Liu W, et al. Among authors: zhang f. Dis Markers. 2021 Nov 19;2021:3514827. doi: 10.1155/2021/3514827. eCollection 2021. Dis Markers. 2021. PMID: 34840628 Free PMC article.

4

Zhang F, Cai J, Hu K, Liu W, Lu S, Tang B, Li M, Wu W, Ren Z, Yin X. Zhang F, et al. Comb Chem High Throughput Screen. 2022;25(13):2203-2216. doi: 10.2174/1386207325666220304115006. Comb Chem High Throughput Screen. 2022. PMID: 35249477

5

Predicting Disease-Specific Survival for Patients With Primary Cholangiocarcinoma Undergoing Curative Resection by Using a Decision Tree Model.

Quan B, Li M, Lu S, Li J, Liu W, Zhang F, Chen R, Ren Z, Yin X. Quan B, et al. Among authors: zhang f. Front Oncol. 2022 Apr 21;12:824541. doi: 10.3389/fonc.2022.824541. eCollection 2022. Front Oncol. 2022. PMID: 35530339 Free PMC article.

6

Construction and Validation of an Epigenetic Regulator Signature as A Novel Biomarker For Prognosis, Immunotherapy, And Chemotherapy In Hepatocellular Carcinoma.

Cai J, Wu S, Zhang F, Dai Z. Cai J, et al. Among authors: zhang f. Front Immunol. 2022 Jul 14;13:952413. doi: 10.3389/fimmu.2022.952413. eCollection 2022. Front Immunol. 2022. PMID: 35911718 Free PMC article.

7

circRanGAP1/miR-27b-3p/NRAS Axis may promote the progression of hepatocellular Carcinoma.

Lin XH, Liu ZY, Zhang DY, Zhang S, Tang WQ, Li DP, Zhang F, Chen RX, Weng SQ, Xue RY, Dong L. Lin XH, et al. Among authors: zhang dy, zhang s, zhang f. Exp Hematol Oncol. 2022 Nov 8;11(1):92. doi: 10.1186/s40164-022-00342-6. Exp Hematol Oncol. 2022. PMID: 36348379 Free PMC article.

8

Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immune Evasion Through PD-L1 Up-Regulation and PMN-Singular Recruitment.

Zhang F, Hu K, Liu W, Quan B, Li M, Lu S, Chen R, Ren Z, Yin X. Zhang F, et al. Cell Mol Gastroenterol Hepatol. 2023;15(3):573-591. doi: 10.1016/j.jcmgh.2022.12.002. Epub 2022 Dec 10. Cell Mol Gastroenterol Hepatol. 2023. PMID: 36513250 Free PMC article.

9

PVR-A Prognostic Biomarker Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma.

Liu WF, Quan B, Li M, Zhang F, Hu KS, Yin X. Liu WF, et al. Among authors: zhang f. Diagnostics (Basel). 2022 Nov 25;12(12):2953. doi: 10.3390/diagnostics12122953. Diagnostics (Basel). 2022. PMID: 36552960 Free PMC article.

10

Gas7 attenuates hepatocellular carcinoma progression and chemoresistance through the PI3K/Akt signaling pathway.

Liu WF, Zhang QW, Quan B, Zhang F, Li M, Lu SX, Dong L, Yin X, Liu BB. Liu WF, et al. Among authors: zhang qw, zhang f. Cell Signal. 2023 Dec;112:110908. doi: 10.1016/j.cellsig.2023.110908. Epub 2023 Sep 27. Cell Signal. 2023. PMID: 37769891

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36,866 results

Search Page

Filters